Man charged with Rochester murder apprehended in Salamanca
Breaking News
August 13, 2025
SALAMANCA — A man charged with the murder of a 28-year-old from Rochester was arrested Monday in Salamanca after a multi-day missing person search acr...
Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
Press Releases
Akeso, Inc.  
April 25, 2025

Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab

HONG KONG, April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from

logo salamanca press

Salamanca Press

Local & Social